These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction). Pu J, Ding S, Ge H, Han Y, Guo J, Lin R, Su X, Zhang H, Chen L, He B, EARLY-MYO Investigators. Circulation; 2017 Oct 17; 136(16):1462-1473. PubMed ID: 28844990 [Abstract] [Full Text] [Related]
3. Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction? Shavadia J, Zheng Y, Dianati Maleki N, Huber K, Halvorsen S, Goldstein P, Gershlick AH, Wilcox R, Van de Werf F, Armstrong PW. J Am Heart Assoc; 2015 Aug 24; 4(8):e002049. PubMed ID: 26304934 [Abstract] [Full Text] [Related]
4. Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study). Welsh RC, Van de Werf F, Westerhout CM, Goldstein P, Gershlick AH, Wilcox RG, Danays T, Bluhmki E, Lopes RD, Steg PG, Armstrong PW. Am J Cardiol; 2014 Sep 15; 114(6):811-9. PubMed ID: 25108302 [Abstract] [Full Text] [Related]
7. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis. Sim DS, Jeong MH, Ahn Y, Kim YJ, Chae SC, Hong TJ, Seong IW, Chae JK, Kim CJ, Cho MC, Rha SW, Bae JH, Seung KB, Park SJ, Korea Acute Myocardial Infarction Registry (KAMIR) Investigators. Circ Cardiovasc Interv; 2016 Sep 15; 9(9):. PubMed ID: 27582112 [Abstract] [Full Text] [Related]
8. Relationship between community hospital versus pre-hospital location of randomisation and clinical outcomes in ST-elevation myocardial infarction patients: insights from the Stream study. Welsh RC, Goldstein P, Sinnaeve P, Ostojic MC, Zheng Y, Danays T, Westerhout CM, Van de Werf F, Armstrong PW. Eur Heart J Acute Cardiovasc Care; 2018 Sep 15; 7(6):504-513. PubMed ID: 28627230 [Abstract] [Full Text] [Related]
9. Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials. Graham JJ, Yan AT, Tan MK, Cantor WJ, DiMario C, Jolly SS, Halvorsen S, Fernandez-Aviles F, Le May MR, Scheller B, Borgia F, Piscione F, Madan M, Goodman SG. Cardiovasc Revasc Med; 2016 Sep 15; 17(5):295-301. PubMed ID: 27116940 [Abstract] [Full Text] [Related]
10. Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry. Zubaid M, Khraishah H, Alahmad B, Rashed W, Ridha M, Alenezi F, Aljarralah M, Al-Marri K, Almutairi M, Althalji K, Alfaddagh A. Ann Glob Health; 2020 Feb 05; 86(1):13. PubMed ID: 32064231 [Abstract] [Full Text] [Related]
11. Safety and Efficacy of a Pharmacoinvasive Strategy in ST-Segment Elevation Myocardial Infarction: A Patient Population Study Comparing a Pharmacoinvasive Strategy With a Primary Percutaneous Coronary Intervention Strategy Within a Regional System. Rashid MK, Guron N, Bernick J, Wells GA, Blondeau M, Chong AY, Dick A, Froeschl MPV, Glover CA, Hibbert B, Labinaz M, Marquis JF, Osborne C, So DY, Le May MR. JACC Cardiovasc Interv; 2016 Oct 10; 9(19):2014-2020. PubMed ID: 27712737 [Abstract] [Full Text] [Related]
12. STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial. Van de Werf F, Ristić AD, Averkov OV, Arias-Mendoza A, Lambert Y, Kerr Saraiva JF, Sepulveda P, Rosell-Ortiz F, French JK, Musić LB, Vandenberghe K, Bogaerts K, Westerhout CM, Pagès A, Danays T, Bainey KR, Sinnaeve P, Goldstein P, Welsh RC, Armstrong PW, STREAM-2 Investigators. Circulation; 2023 Aug 29; 148(9):753-764. PubMed ID: 37439219 [Abstract] [Full Text] [Related]
13. Impact of Access Site Practice on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention Following Thrombolysis for ST-Segment Elevation Myocardial Infarction in the United Kingdom: An Insight From the British Cardiovascular Intervention Society Dataset. Rashid M, Rushton CA, Kwok CS, Kinnaird T, Kontopantelis E, Olier I, Ludman P, De Belder MA, Nolan J, Mamas MA. JACC Cardiovasc Interv; 2017 Nov 27; 10(22):2258-2265. PubMed ID: 29169494 [Abstract] [Full Text] [Related]
14. Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy. Porto I, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay JF, Ten Berg J, Widimský P, Le Gall N, Zagar AJ, LeNarz LA, Miller D, Montalescot G, ACCOAST Investigators. JACC Cardiovasc Interv; 2016 May 09; 9(9):897-907. PubMed ID: 27151605 [Abstract] [Full Text] [Related]
15. Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network). Siontis KC, Barsness GW, Lennon RJ, Holmen JL, Wright RS, Bell MR, Gersh BJ. Am J Cardiol; 2016 Jun 15; 117(12):1904-10. PubMed ID: 27131614 [Abstract] [Full Text] [Related]
16. Reperfusion in Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock and Prolonged Interhospital Transport Times. van Diepen S, Zheng Y, Senaratne JM, Tyrrell BD, Das D, Thiele H, Henry TD, Bainey KR, Welsh RC. Circ Cardiovasc Interv; 2024 Feb 15; 17(2):e013415. PubMed ID: 38293830 [Abstract] [Full Text] [Related]
17. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Armstrong PW, WEST Steering Committee. Eur Heart J; 2006 Jul 15; 27(13):1530-8. PubMed ID: 16757491 [Abstract] [Full Text] [Related]
18. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Tang X, Li R, Jing Q, Wang Q, Liu P, Zhang P, Liu Y. J Cardiovasc Pharmacol; 2016 Aug 15; 68(2):115-20. PubMed ID: 27010809 [Abstract] [Full Text] [Related]
19. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice? Mamas MA, Ratib K, Routledge H, Neyses L, Fraser DG, de Belder M, Ludman PF, Nolan J, British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research. JACC Cardiovasc Interv; 2013 Jul 15; 6(7):698-706. PubMed ID: 23769648 [Abstract] [Full Text] [Related]
20. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, Sulimov V, Rosell Ortiz F, Ostojic M, Welsh RC, Carvalho AC, Nanas J, Arntz HR, Halvorsen S, Huber K, Grajek S, Fresco C, Bluhmki E, Regelin A, Vandenberghe K, Bogaerts K, Van de Werf F, STREAM Investigative Team. N Engl J Med; 2013 Apr 11; 368(15):1379-87. PubMed ID: 23473396 [Abstract] [Full Text] [Related] Page: [Next] [New Search]